We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

A white blood cell.

Promising Treatment Approach for Aggressive Leukemia Identified

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immune Cells “Remember” the Pain of Newborn Injuries

News

Affymetrix Announces Proposed $105 Million Offering of Convertible Senior Notes Due 2019

Company expects to grant an option to purchase up to $10 million aggregate principal amount of additional notes.

Asuragen Grants Armored RNA® Technology License to BD

Asuragen to develop and supply reagents for BD Diagnostics in Asuragen’s cGMP manufacturing facility.

New Partnership Advances SeptiCyte®

Immunexpress, Debiopharm, and Biocartis announce collaboration to advance development of SeptiCyte® Triage for managing sepsis.

Life Technologies to Collaborate with Boston Children's Hospital

Collaboration to develop an optimized lab workflow based on the Ion Proton™ sequencer.

CellCentric and ZoBio Enter into Partnership

Both Companies are working together to develop lead compounds against epigenetic drug targets.

AMRI Further Expands Discovery Capabilities in India

Two strategic hires bring additional flexibility to global drug discovery operations.

Opportunities and Challenges for Nutritional Proteomics in Cancer Prevention

Articles presented in this supplement are from talks proffered in the “Nutrition Proteomics and Cancer Prevention” session at the American Institute for Cancer Research Annual Research Conference on Food, Nutrition, Physical Activity and Cancer.

Bruker and JMI Laboratories Announce Collaboration for Mass Spectrometry

The collaboration sees Bruker and JMI Laboratories partner in the field of fungal identification by proteomics fingerprinting.

e-Therapeutics’ ETS2101 Enters Phase I Clinical Trial in Brain Cancer

First findings are expected in late 2012.

Multiplicom’s BRCA MASTR™ Dx Test Accredited with CE/IVD Mark

BRCA MASTR Dx will be shipped throughout Europe from September 2012.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter